Evidence map›Paper›PMID 37056061›Full record

ArticleCombinatorial chemistry & high throughput screening2024

A Feature Selection Method Based on Graph Theory for Cancer Classification.

Kai Zhou, Zhixiang Yin, Jiaying Gu, Zhiliang Zeng

Abstract read
PubMed Publisher
In one paragraph

Article in Combinatorial chemistry & high throughput screening, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kai ZhouSchool of Mathematics, Physics and Statistics, Shanghai University of Engineering Science, Shanghai, 201620, China.
Zhixiang YinSchool of Mathematics, Physics and Statistics, Shanghai University of Engineering Science, Shanghai, 201620, China.
Jiaying GuSchool of Mathematics, Physics and Statistics, Shanghai University of Engineering Science, Shanghai, 201620, China.
Zhiliang ZengSchool of Mathematics, Physics and Statistics, Shanghai University of Engineering Science, Shanghai, 201620, China.

Funding

National Natural Science Foundation of China (NSFC) 62072296? 61672001
6 · The paper itself

Abstract

objectiveGene expression profile data is a good data source for people to study tumors, but gene expression data has the characteristics of high dimension and redundancy. Therefore, gene selection is a very important step in microarray data classification.

methodsIn this paper, a feature selection method based on the maximum mutual information coefficient and graph theory is proposed. Each feature of gene expression data is treated as a vertex of the graph, and the maximum mutual information coefficient between genes is used to measure the relationship between the vertices to construct an undirected graph, and then the core and coritivity theory is used to determine the feature subset of gene data.

resultsIn this work, we used three different classification models and three different evaluation metrics such as accuracy, F1-Score, and AUC to evaluate the classification performance to avoid reliance on any one classifier or evaluation metric. The experimental results on six different types of genetic data show that our proposed algorithm has high accuracy and robustness compared to other advanced feature selection methods.

conclusionIn this method, the importance and correlation of features are considered at the same time, and the problem of gene selection in microarray data classification is solved.

Indexed as

AlgorithmsNeoplasmsGene Expression ProfilingHumansOligonucleotide Array Sequence Analysiscancer classificationfeature selectionfilters.Gene expressiongraph theoryMIC

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.